These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3784967)

  • 1. Transdermal estrogen.
    Med Lett Drugs Ther; 1986 Dec; 28(728):119-20. PubMed ID: 3784967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transdermal estrogen substitution in the postmenopause].
    Fontana-Klaiber H; Koller J; Keller PJ
    Gynakol Rundsch; 1987; 27(4):225-33. PubMed ID: 3436573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of transdermal administration of 17-beta-estradiol in the management of menopause].
    Grio R; Piacentino R; Abbondanza M; Cirnigliaro C; Fusi D; Corsello FP; Arrichiello G; Canestrelli M; Marchino GL
    Minerva Ginecol; 1992; 44(1-2):19-21. PubMed ID: 1508379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrasorb.
    Chiechi LM
    IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
    Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal hormone replacement therapy, serum lipids and lipoproteins.
    Crook D; Stevenson JC
    Br J Clin Pract Suppl; 1996 Sep; 86():17-21. PubMed ID: 8995006
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen substitution using a transdermal system].
    Schenkel L; Barlier D; Gay C; Gschwind T
    Rev Fr Gynecol Obstet; 1988 Jun; 83(6):453-8. PubMed ID: 3043634
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch.
    Liang R; Wong RW; Cheng IK
    Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965
    [No Abstract]   [Full Text] [Related]  

  • 9. A decade of experience with transdermal estrogen replacement therapy: overview of key pharmacologic and clinical findings.
    Corson SL
    Int J Fertil; 1993; 38(2):79-91. PubMed ID: 8097503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systen--transdermal estradiol for substitution following surgical menopause].
    Rachev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An estradiol matrix transdermal system for the prevention of postmenopausal bone loss.
    McKeever C; McIlwain H; Greenwald M; Gupta N; Jayawardene S; Huels G; Roberts M
    Clin Ther; 2000 Jul; 22(7):845-57. PubMed ID: 10945511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
    Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
    Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Systen, a new transdermal form of hormone replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():36-44. PubMed ID: 8499958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of hormone replacement therapy (HRT) on lipid metabolism in the menopause].
    Camilli A; Di Benedetto L; Camilli FM; Ermini M
    Minerva Ginecol; 1997 May; 49(5):199-202. PubMed ID: 9304079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic sensitization to 17-beta estradiol induced by transcutaneous administration].
    El Sayed F; Bayle-Lebey P; Marguery MC; Bazex J
    Ann Dermatol Venereol; 1996; 123(1):26-8. PubMed ID: 8734113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.